Compare ADMA & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | WB |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | United States | China |
| Employees | 647 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2012 | 2014 |
| Metric | ADMA | WB |
|---|---|---|
| Price | $8.44 | $8.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $25.67 | $14.00 |
| AVG Volume (30 Days) | ★ 2.6M | 773.1K |
| Earning Date | 05-06-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 7.49% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $42,219,783.00 | N/A |
| Revenue This Year | $27.46 | $8.35 |
| Revenue Next Year | $22.11 | $1.73 |
| P/E Ratio | $45.79 | ★ $5.66 |
| Revenue Growth | ★ 43.85 | N/A |
| 52 Week Low | $7.21 | $7.09 |
| 52 Week High | $20.46 | $12.96 |
| Indicator | ADMA | WB |
|---|---|---|
| Relative Strength Index (RSI) | 43.53 | 64.01 |
| Support Level | $8.20 | $8.10 |
| Resistance Level | $8.97 | $8.77 |
| Average True Range (ATR) | 0.26 | 0.15 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 28.57 | 91.18 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.